Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RegenMatrix is an Italian biotechnology company specializing in the development and manufacturing of advanced biomaterials for tissue regeneration. The company's core technology centers on a proprietary collagen-based matrix designed to facilitate bone and soft tissue repair in dental, orthopedic, and dermatological applications. Their products are engineered to provide a scaffold that promotes natural healing and integration within the host tissue. RegenMatrix focuses on bridging the gap between research and clinical application through high-quality, biocompatible solutions. The company maintains a strong focus on the 'Made in Italy' quality standard for its regenerative products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RegenMatrix.